Teva Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Teva Pharma (TEVA) Reports In-Line Q1 EPS; Narrows Guidance
May 3, 2022 7:08 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $0.55, in-line with the analyst estimate of $0.55. Revenue for the quarter came in at $3.7 billion versus the consensus estimate of $3.74 billion.
GUIDANCE:
Teva Pharma sees FY2022 EPS of $2.40-$2.60, versus the consensus of $2.51.... More
